PAPER Cannon A, Fujioka S, Rutherford NJ, Ferman TJ, Broderick DF, Boylan KB, Graff-Radford NR, Uitti RJ, Rademakers R, Wszolek ZK, Dickson DW
SEARCH RESULTS
331209 RESULTS
PAPER Zinkie S, Gentil BJ, Minotti S, Durham HD
Expression of the protein chaperone, clusterin, in spinal cord cells constitutively and following cellular stress, and upregulation by treatment with Hsp90 inhibitor.
Cell Stress Chaperones. 2013 Apr 19; PubMed: 23595219PAPER Ries J, Udayar V, Soragni A, Hornemann S, Nilsson KP, Riek R, Hock C, Ewers H, Aguzzi AA, Rajendran L
Superresolution Imaging of Amyloid Fibrils with Binding-Activated Probes.
ACS Chem Neurosci. 2013 Apr 22; PubMed: 23594172PAPER Lazzarini M, Martin S, Mitkovski M, Vozari RR, Stühmer W, Bel ED
Doxycycline restrains glia and confers neuroprotection in a 6-OHDA Parkinson model.
Glia. 2013 Jul;61(7):1084-100. PubMed: 23595698PAPER Zeng X, Wang T, Jiang L, Ma G, Tan S, Li J, Gao J, Liu K, Zhang Y
Diazoxide and cyclosporin A protect primary cholinergic neurons against beta-amyloid (1-42)-induced cytotoxicity.
Neurol Res. 2013 Jun;35(5):529-36. PubMed: 23595141PAPER Esposito Z, Belli L, Toniolo S, Sancesario G, Bianconi C, Martorana A
Amyloid β, Glutamate, Excitotoxicity in Alzheimer's Disease: Are We on the Right Track?
CNS Neurosci Ther. 2013 Apr 18; PubMed: 23593992PAPER Fernandez R, Monacelli A, Duffy CJ
Visual motion event related potentials distinguish aging and Alzheimer's disease.
J Alzheimers Dis. 2013 Jan 1;36(1):177-83. PubMed: 23594601PAPER Manczak M, Reddy PH
Abnormal Interaction of Oligomeric Amyloid-β with Phosphorylated Tau: Implications to Synaptic Dysfunction and Neuronal Damage.
J Alzheimers Dis. 2013 Jan 1;36(2):285-95. PubMed: 23594602PAPER
Upcoming meetings related to Alzheimer's disease.
Value Health. 2013 May;16(3):A101. PubMed: 23594700PAPER Fukazawa R, Hanyu H, Sato T, Shimizu S, Koyama S, Kanetaka H, Sakurai H, Iwamoto T
Subgroups of Alzheimer's disease associated with diabetes mellitus based on brain imaging.
Dement Geriatr Cogn Disord. 2013;35(5-6):280-90. PubMed: 23594859PAPER Morimoto BH, Schmechel D, Hirman J, Blackwell A, Keith J, Gold M,
A double-blind, placebo-controlled, ascending-dose, randomized study to evaluate the safety, tolerability and effects on cognition of AL-108 after 12 weeks of intranasal administration in subjects with mild cognitive impairment.
Dement Geriatr Cogn Disord. 2013;35(5-6):325-36. PubMed: 23594991PAPER Hokama M, Oka S, Leon J, Ninomiya T, Honda H, Sasaki K, Iwaki T, Ohara T, Sasaki T, Laferla FM, Kiyohara Y, Nakabeppu Y
Altered Expression of Diabetes-Related Genes in Alzheimer's Disease Brains: The Hisayama Study.
Cereb Cortex. 2013 Apr 17; PubMed: 23595620PAPER Corbett BF, Leiser SC, Ling HP, Nagy R, Breysse N, Zhang X, Hazra A, Wood A, Pangalos MN, Reinhart PH, Chin J
Sodium channel cleavage is associated with aberrant neuronal activity and cognitive deficits in a mouse model of Alzheimer's disease.
J Neurosci. 2013 Apr 17;33(16):7020-6. PubMed: 23595759PAPER Liu B, Frost JL, Sun J, Fu H, Grimes S, Blackburn P, Lemere CA
MER5101, a novel Aβ1-15:DT conjugate vaccine, generates a robust anti-Aβ antibody response and attenuates Aβ pathology and cognitive deficits in APPswe/PS1ΔE9 transgenic mice.
J Neurosci. 2013 Apr 17;33(16):7027-37. PubMed: 23595760PAPER Galimberti D, Scarpini E
Progress in Alzheimer's disease research in the last year.
J Neurol. 2013 Jul;260(7):1936-41. PubMed: 23595792Current Filters
No filters selected